Association of Interferon-alpha and bone density in patients with hepatitis C
Background: Chronic hepatitis is a variety of liver dysfunctions with different causes and severities in which inflammation and necrosis last for at least six months. Choice treatment for all chronic viral hepatitis is interferon Alpha (IFN-α). Decreasing bone mass density (BMD) may lead t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bushehr University of Medical Sciences
2014-11-01
|
Series: | Iranian South Medical Journal |
Subjects: | |
Online Access: | http://ismj.bpums.ac.ir/browse.php?a_code=A-10-3-512&slc_lang=en&sid=1 |